Meditation and Opioid Consumption in Total Joint Replacement Patients Undergo Primary Total Hip a… (NCT05669066) | Clinical Trial Compass
CompletedNot Applicable
Meditation and Opioid Consumption in Total Joint Replacement Patients Undergo Primary Total Hip and Knee Replacement
United States29 participantsStarted 2017-07-10
Plain-language summary
The main purpose of this study is to look at whether meditation techniques can help reduce pain and opioid use after surgery.
Who can participate
Age range18 Years – 89 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Male and female, ages 18-89 years
* Narcotic naive patients ("Narcotic naïve" for the purpose of this study will be no history of narcotic tolerance prior to surgery, defined by the FDA as greater than or equal to 60mg oral morphine equivalents per day for 7 days or longer)
* Scheduled for primary total knee replacement for osteoarthritis
* Willing to sign informed consent form
Exclusion Criteria:
* • Surgery to be performed for other disease entities (e.g., inflammatory arthritis, post septic arthritis, posttraumatic arthritis or acute fracture)
* History of narcotic tolerance prior to surgery (defined by the FDA as greater than or equal to 60mg oral morphine equivalents per day for 7 days or longer)
* Currently taking non-narcotic analgesics other than acetaminophen and non-steroidal anti-inflammatory medications (e.g. Tramadol)
* History of pain syndromes (e.g., fibromyalgia, complex regional pain syndrome, chronic low back pain)
* Dementia or other disorder of cognitive function that precludes study consent and/or participation in the MM program
* In investigator's opinion, unable to complete study tasks over 12-month follow-up period